CombiMatrix to Present at the 26th Annual ROTH Conference
March 04 2014 - 6:00AM
CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics
company specializing in DNA-based testing services for
developmental disorders and cancer diagnostics, today announced
that CEO Mark McDonough is scheduled to present at the 26th Annual
ROTH Conference on Wednesday, March 12, 2014 at 11:30 am Pacific
Time. The conference is being held at the Ritz-Carlton in Dana
Point, California on March 9-12, 2014.
To view the presentation via CombiMatrix's website, go to
www.combimatrix.com in the Investor/Events section
(http://investor.combimatrix.com/events.cfm). A replay of the
webcast will be available for 90 days at the site after the
presentation.
About CombiMatrix Corporation
CombiMatrix Corporation provides valuable molecular diagnostic
solutions and comprehensive clinical support to foster the highest
quality in patient care. CombiMatrix specializes in miscarriage
analysis, prenatal testing and pediatric genetics, offering
DNA‑based testing for the detection of genetic abnormalities beyond
what can be identified through traditional methodologies.
CombiMatrix performs genetic testing utilizing a variety of
advanced cytogenomic techniques, including chromosomal microarray,
standardized and customized fluorescence in situ hybridization
("FISH") and high-resolution karyotyping. CombiMatrix is dedicated
to providing high-level clinical support for healthcare
professionals in order to help them incorporate the results of
complex genetic testing into patient-centered medical decision
making. Additional information about CombiMatrix is available at
www.combimatrix.com or by calling 1-800-710-0624.
CONTACT: Company Contact:
Mark McDonough
President & CEO, CombiMatrix Corporation
Tel (949) 753-0624
Investor Relations / Media Contact:
Rene Caron
Allen & Caron, Inc.
Tel (949) 474-4300
rene@allencaron.com
Combimatrix Corp. (MM) (NASDAQ:CBMX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Combimatrix Corp. (MM) (NASDAQ:CBMX)
Historical Stock Chart
From Apr 2023 to Apr 2024